RenovoRx, Inc.
RNXT
Rank in Stocks
#22462
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to... RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California.
Share Price
$1.18
Last synced: 2026-11-09
Market Cap
$53.25M
Change (1 day)
4.42%
Change (1 year)
10.28%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade RenovoRx, Inc. (RNXT)
Category
Healthcare
EPS for RenovoRx, Inc. (RNXT)
EPS as of September 2026 TTM: $-0.32
According to RenovoRx, Inc.'s latest financial reports, its current EPS (TTM) is $-0.32. At the end of 2025 the company had an EPS of $-0.32, an increase over its 2024 EPS of $-0.37.
EPS history for RenovoRx, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.32 | 0.00% |
| 2025 | $-0.32 | -13.51% |
| 2024 | $-0.37 | -26.00% |
| 2023 | $-0.50 | -7.41% |
| 2022 | $-0.54 | 35.00% |
| 2021 | $-0.40 | 60.00% |
| 2020 | $-0.25 | 13.64% |
| 2019 | $-0.22 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -4,993.75% |
US
|
|
| $-7.07 | 2,109.38% |
US
|
|
| $-5.29 | 1,553.13% |
AU
|
|
| $12.88 | -4,125.03% |
BE
|
|
| $21.56 | -6,837.50% |
NL
|
Questions about RenovoRx, Inc.'s earnings per share (EPS)
What is RenovoRx, Inc.'s earnings per share (EPS)?
RenovoRx, Inc.'s earnings per share (EPS) over the last twelve months is $-0.32, as of Sep 2026.
What was RenovoRx, Inc.'s earnings per share (EPS) in 2025?
In 2025, RenovoRx, Inc.'s earnings per share (EPS) was $-0.32, compared with $-0.37 in 2024.
How has RenovoRx, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, RenovoRx, Inc.'s earnings per share (EPS) was highest in 2020 ($-0.25) and lowest in 2022 ($-0.54).
How does RenovoRx, Inc.'s earnings per share (EPS) compare with similar companies?
RenovoRx, Inc.'s earnings per share (EPS) ($-0.32) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.